000908135 000__ 01268cam\a2200349Ia\4500
000908135 001__ 908135
000908135 005__ 20210515182524.0
000908135 006__ m\\\\\o\\d\\\\\\\\
000908135 007__ cr\cn\nnnunnun
000908135 008__ 120903s2012\\\\enka\\\\ob\\\\001\0\eng\d
000908135 020__ $$z9780199742868
000908135 020__ $$z9780199780372
000908135 035__ $$a(MiAaPQ)EBC995859
000908135 035__ $$a(Au-PeEL)EBL995859
000908135 035__ $$a(CaPaEBR)ebr10589616
000908135 035__ $$a(CaONFJC)MIL388980
000908135 035__ $$a(OCoLC)806039918
000908135 040__ $$aMiAaPQ$$cMiAaPQ$$dMiAaPQ
000908135 050_4 $$aRC632.L5$$bD97 2012
000908135 24500 $$aDyslipidemia$$h[electronic resource] /$$cRagavendra R. Baliga, Christopher P. Cannon.
000908135 260__ $$aOxford ;$$aNew York :$$bOxford University Press,$$c2012.
000908135 300__ $$axii, 139 p. :$$bill.
000908135 504__ $$aIncludes bibliographical references and index.
000908135 506__ $$aAccess limited to authorized users.
000908135 650_0 $$aLipids$$xMetabolism$$xDisorders$$xTreatment.
000908135 650_0 $$aAtherosclerosis$$xTreatment.
000908135 650_0 $$aCoronary heart disease.
000908135 7001_ $$aBaliga, R. R.
000908135 7001_ $$aCannon, Christopher P.
000908135 852__ $$bebk
000908135 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=995859$$zOnline Access
000908135 909CO $$ooai:library.usi.edu:908135$$pGLOBAL_SET
000908135 980__ $$aEBOOK
000908135 980__ $$aBIB
000908135 982__ $$aEbook
000908135 983__ $$aOnline